Top Stocks: MGM Resorts International (NYSE:MGM), EMC Corporation (NYSE:EMC), Meridian Bancorp (NASDAQ:EBSB), CME Group Inc. (NASDAQ:CME), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)

MGM Resorts International (NYSE:MGM) plans to open an $800 million casino in nearby Springfield, Massachusetts, within about 2 1/2 years. On Thursday shares of MGM Resorts International (NYSE:MGM) closed at $19.72. Company’s sales growth for last 5 years was 10.90% and EPS growth for next 5 years is recorded as 10.00%.

Capgemini and EMC Corporation (NYSE:EMC) published the results of a survey yesterday (March 10th) showing that almost two-thirds (64 per cent) of enterprises believe big data is “changing traditional business boundaries” and “enabling new providers to move into their industry”. On last trading day EMC Corporation (NYSE:EMC) moved up 1.75% to close at $26.17. Its volatility for the week is 2.75% while volatility for the month is 1.94%. EMC’s sales growth for past 5 years was 11.70% and its EPS growth for past 5 years was 20.00%. EMC Corporation (NYSE:EMC) monthly performance is -3.93%.

Meridian Bancorp, Inc. (NASDAQ:EBSB)’s stock hold a Zacks Rank #1 (Strong Buy). On last trading day Meridian Bancorp, Inc. (NASDAQ:EBSB) advanced 1.68% to close at $12.70. Its volatility for the week is 1.68% while volatility for the month is 1.63%. EBSB’s sales growth for past 5 years was 13.90% and its EPS growth for past 5 years was 43.10%. Meridian Bancorp, Inc. (NASDAQ:EBSB) monthly performance is 4.27%.

CME Group Inc. (NASDAQ:CME) announced the winners of its 12th annual CME Group Trading Challenge. The four-week electronic trading competition is open exclusively to teams of currently enrolled graduate and undergraduate students around the world. The students compete on a real-time professional trading platform, provided by CQG, while learning about market events by accessing live Dow Jones newsfeeds and The Hightower Report. CME Group Inc. (NASDAQ:CME) has 0.20% insider ownership while its institutional ownership stands at 77.40%. In last trading activity company’s stock closed at $97.33.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on March 10, 2015, reported that the United States District Court for the District of Massachusetts dismissed the shareholder derivative lawsuit filed in late 2013 against the Company and certain of its officers and directors in connection with the events leading up to the temporary suspension of the marketing and commercial distribution of Iclusig® (ponatinib) on October 31, 2013, and subsequent re-launch in January 2014 based on revised U.S. prescribing information and a risk evaluation and mitigation strategy. On last trading day Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) moved up 1.22% to close at $8.28. Its volatility for the week is 3.73% while volatility for the month is 4.49%. ARIA’s sales growth for past 5 years was 66.20% and its EPS growth for past 5 years was -0.20%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) monthly performance is 21.76%.

Leave a Reply

Your email address will not be published. Required fields are marked *

*